U.S. market Closed. Opens in 7 hours 53 minutes

VVOS | Vivos Therapeutics, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 2.6100 - 2.7500
52 Week Range 1.9100 - 48.79
Beta 3.96
Implied Volatility 271.22%
IV Rank 79.23%
Day's Volume 54,297
Average Volume 1,350,314
Shares Outstanding 4,765,300
Market Cap 12,818,657
Sector Healthcare
Industry Medical - Devices
IPO Date 2020-12-11
Valuation
Profitability
Growth
Health
P/E Ratio -0.40
Forward P/E Ratio N/A
EPS -6.80
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 114
Country USA
Website VVOS
Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for adult patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA). The Vivos treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Vivos oral appliances have been used to treat over 15,000 patients worldwide by more than 1,100 trained dentists.
VVOS's peers: AEMD, BBLG, BSGM, BVS, CODX, ECOR, HSDT, IINN, MYO, NAOV, NSPR, NURO, QTRX, RPID, TIVC, BJDX, TLIS, NUWE, HSCS
*Chart delayed
Analyzing fundamentals for VVOS we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is frighteningly weak. For more detailed analysis please see VVOS Fundamentals page.

Watching at VVOS technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on VVOS Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙